v3.22.2.2
Condensed Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Unvested restricted stock units
Additional Paid-In Capital
Accumulated Deficit
Beginning balance, common stock (in shares) at Dec. 31, 2020   25,890,490      
Beginning balance at Dec. 31, 2020 $ 186,659 $ 26   $ 341,384 $ (154,751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (18,909)       (18,909)
Issuance of common stock upon exercise of stock options (in shares)   55,046      
Issuance of common stock upon exercise of stock options 218     218  
Issuance of common stock upon vesting of restricted stock units (in shares)     15,252    
Stock-based compensation expense 2,680     2,680  
Ending balance, common stock (in shares) at Mar. 31, 2021   25,960,788      
Ending balance at Mar. 31, 2021 170,648 $ 26   344,282 (173,660)
Beginning balance, common stock (in shares) at Dec. 31, 2020   25,890,490      
Beginning balance at Dec. 31, 2020 186,659 $ 26   341,384 (154,751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (58,595)        
Ending balance, common stock (in shares) at Sep. 30, 2021   26,094,253      
Ending balance at Sep. 30, 2021 137,512 $ 26   350,832 (213,346)
Beginning balance, common stock (in shares) at Mar. 31, 2021   25,960,788      
Beginning balance at Mar. 31, 2021 170,648 $ 26   344,282 (173,660)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (22,016)       (22,016)
Issuance of common stock upon exercise of stock options (in shares)   28,748      
Issuance of common stock upon exercise of stock options 104     104  
Issuance of common stock upon vesting of restricted stock units (in shares)     16,901    
Stock-based compensation expense 3,048     3,048  
Ending balance, common stock (in shares) at Jun. 30, 2021   26,006,437      
Ending balance at Jun. 30, 2021 151,784 $ 26   347,434 (195,676)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (17,670)       (17,670)
Issuance of common stock upon exercise of stock options (in shares)   87,816      
Issuance of common stock upon exercise of stock options       283  
Stock-based compensation expense       3,115  
Ending balance, common stock (in shares) at Sep. 30, 2021   26,094,253      
Ending balance at Sep. 30, 2021 $ 137,512 $ 26   350,832 (213,346)
Beginning balance, common stock (in shares) at Dec. 31, 2021 26,579,585 26,579,585      
Beginning balance at Dec. 31, 2021 $ 99,537 $ 27   354,920 (255,410)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (47,892)       (47,892)
Issuance of common stock upon exercise of stock options (in shares)   69,930      
Issuance of common stock upon exercise of stock options 76     76  
Issuance of common stock upon vesting of restricted stock units (in shares)     20,618    
Shares withheld for taxes (in shares)   (7,436)      
Shares withheld for taxes (87)     (87)  
Stock-based compensation expense 4,359     4,359  
Ending balance, common stock (in shares) at Mar. 31, 2022   26,662,697      
Ending balance at Mar. 31, 2022 $ 55,993 $ 27   359,268 (303,302)
Beginning balance, common stock (in shares) at Dec. 31, 2021 26,579,585 26,579,585      
Beginning balance at Dec. 31, 2021 $ 99,537 $ 27   354,920 (255,410)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (134,581)        
Issuance of common stock upon exercise of stock options (in shares) 69,930        
Ending balance, common stock (in shares) at Sep. 30, 2022 26,831,485 26,831,485      
Ending balance at Sep. 30, 2022 $ (22,202) $ 27   367,762 (389,991)
Beginning balance, common stock (in shares) at Mar. 31, 2022   26,662,697      
Beginning balance at Mar. 31, 2022 55,993 $ 27   359,268 (303,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (49,942)       (49,942)
Issuance of common stock upon vesting of restricted stock units (in shares)   37,550      
Issuance of common stock under the employee stock purchase plan (ESPP) 541     541  
Issuance of common stock under the employee stock purchase plan (ESPP) (in shares)   128,926      
Stock-based compensation expense 4,183     4,183  
Ending balance, common stock (in shares) at Jun. 30, 2022   26,829,173      
Ending balance at Jun. 30, 2022 10,775 $ 27   363,992 (353,244)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (36,747)       (36,747)
Issuance of common stock upon vesting of restricted stock units (in shares)     2,312    
Stock-based compensation expense $ 3,770     3,770  
Ending balance, common stock (in shares) at Sep. 30, 2022 26,831,485 26,831,485      
Ending balance at Sep. 30, 2022 $ (22,202) $ 27   $ 367,762 $ (389,991)